-+ 0.00%
-+ 0.00%
-+ 0.00%

Adaptive Biotechnologies President and COO Julie Rubinstein Reports Sale of $708,557.50 in Common Shares

PUBT·11/11/2026 00:27:17
Listen to the news
Adaptive Biotechnologies President and COO Julie Rubinstein Reports Sale of $708,557.50 in Common Shares
  • Adaptive Biotechnologies President and COO Julie Rubinstein sold 23,762 common shares on Nov. 9-10, 2026.
  • Sales were executed at reported weighted-average prices ranging from $28.87 to $30.58 per share.
  • Rubinstein also exercised stock options for 23,762 common shares at $12.14 per share.
  • Following the transactions, direct holdings totaled 377,802 common shares, with 35,228 stock options remaining.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780664-26-000053), on November 10, 2026, and is solely responsible for the information contained therein.